Patents
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
02/1999
02/24/1999CN1209139A Prodrugs of thrombin inhibitors
02/24/1999CN1209111A Prepn. method of physiologically active compound
02/23/1999US5874609 Process for crystallizing L-α-aspartyl-L-phenylanlanine methyl ester
02/23/1999US5874572 Process for preparing cyclosporin A
02/23/1999US5874569 Method of preparing tresyl-activated dextran, article having tresyl-activated dextran fixed covalently to its surface, and immobilization of chemical compounds thereto
02/23/1999US5874544 Antibodies to APO(A)
02/23/1999US5874541 Immunoglobulin or fragment is modified such that heavy chain variable region have been replaced by specific sequence or amino acids of a heavy chain immunogloblin comprising two heavy polypeptide chain consisting of antigen binding site
02/23/1999US5874532 Method for solution phase synthesis of oligonucleotides and peptides
02/23/1999US5874401 Cedar pollen protein and use thereof in treating, preventing, and diagnosing pollenosis
02/23/1999US5874399 Progenitor B cell stimulating factor
02/23/1999US5874253 Expression vectors and genetic engineering
02/23/1999US5874247 Protein disulfide isomerase and method of using
02/23/1999US5874239 Biotinylation of proteins
02/23/1999US5874214 Useful for identification, tracking and categorization of components of complex mixtures of diverse molecules; drug delivery
02/23/1999US5874086 Synthetic polypeptide analogs of parathyroid hormone (pth), parathyroid hormone related peptide (pthrp), and of the physiologically active truncated homologs and analogs of pth and pthrp; forming an amphipathic alpha-helix
02/23/1999US5874076 Immunomodulators; antitumor,-carcinogenic agents; extracted from a recombinant microorganism; separated from reduced interleukin (cysteine) from the oxidized interleukin (cystine)
02/23/1999CA1340401C Cell surface protein, process for its preparation, and the use of a cell surface protein thus obtained
02/18/1999WO1999007750A1 Perfluorinated resins as a support for solid phase reactions
02/18/1999WO1999007727A1 Eukaryotic disulfide bond-forming proteins and related molecules and methods
02/18/1999WO1999007458A1 Hollow fiber co-flow filtration device
02/17/1999EP0896582A1 Non-dendritic backbone peptide carrier
02/17/1999EP0896579A1 Recovery of proteins by precipitation using lignosulfonates
02/17/1999CN1207946A Thioether conjugates
02/16/1999US5872221 Capable of binding epitopes of pthrp and a kit for the detection of pthrp or fragments thereof comprising one or more antibody reagents capable of binding to epitopes of pthrp
02/16/1999US5872100 Peptides containing D-2-Alkyl-Tryptophan
02/16/1999US5872099 Administering high molecular weight fraction having higher platelet aggregation activity; treatment of hemophilia a and other blood disorders
02/16/1999US5872001 Lanthionine antibiotic compositions and methods
02/16/1999US5871995 Purified enzymes participating in C-terminal amidation
02/16/1999US5871970 Calcium-binding protein
02/16/1999US5871954 Acylation of peptide or protein by reacting with coenzyme a ester of an oxy- or thio-substituted fatty acid analog in presence of n-myristoyl transferase
02/16/1999US5871945 Modulators of anchoring protein function
02/16/1999US5871933 Diagnosing, screening, and confirming infection with accuracy; vaccines
02/16/1999US5871928 Methods for nucleic acid analysis
02/16/1999US5871711 Radioactively-labeled somatostatin-derived peptides for imaging and therapeutic uses
02/16/1999CA2138020C Pharmaceutical composition containing botulinum b complex
02/16/1999CA2122112C Adrenomedullin
02/16/1999CA1340391C Monoclonal antibodies against atrial, natriuretic peptides of humans
02/11/1999WO1999006534A1 Production of avian embryonic germ (eg) cell lines by prolonged culturing of pgcs, use thereof for cloning and chimerization
02/11/1999WO1999006440A1 Novel synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome
02/11/1999WO1999006067A1 Method of removing endotoxin from vaccines
02/11/1999WO1999006057A1 Soya extract, process for its preparation and pharmaceutical composition
02/11/1999WO1998050556A3 Intracellular production of hepatitis c e1 and e2 truncated polypeptides
02/11/1999CA2300336A1 Production of avian embryonic germ (eg) cell lines by prolonged culturing of pgcs, use thereof for cloning and chimerization
02/11/1999CA2298101A1 Novel synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome
02/10/1999EP0896000A1 Process for isolation of 1-[N2-((S-Ethoxycarbonyl)-3-phenylpropyl)-N6-trifluoroacetyl]-L-lysyl-L-proline (Lisinopril (Tfa) ethylester, LPE)
02/10/1999EP0895546A1 Methods of isolating biological target materials using silica magnetic particles
02/10/1999EP0669940B1 Specifically crosslinked hemoglobin with free functionality
02/10/1999CN1207394A Method for extracting chicken nucleic acid and nucleoprotein from chicken blood
02/09/1999US5869631 A newly isolated human immunodeficiency virus capable of causing aids; having genetic polymorphism with variablility in the envelope region and glycosylation; detection and diagnosis of aids
02/09/1999US5869617 High and low molecular weight fractions of von Willebrand Factor and preparations of same
02/09/1999US5869606 Amino acids peptides or derivatives thereof coupled to fats
02/09/1999US5869605 For multistage biosynthesis
02/09/1999US5869604 Using exogenous nucleating agent with areal lattice match of 90.4% to polypeptide, crystallization, separating high purity crystal attached to agent from unattached contaminated crystal; polypeptide is not canavalin or concanavalin b
02/09/1999US5869579 Chloromethylated divinybenzene-styrene resin modified with branched diol and carbonyldiimidazole; intermediates
02/09/1999US5869466 Vitamin B12 mediated oral delivery systems for GCSF
02/09/1999US5869449 Improved antibacterial activity against some clinical isolates of staphylococci somewhat resistant to teicoplanin.
02/09/1999US5869447 Cyclohexapeptides and their mixtures, a process for preparing them, and their use
02/09/1999US5869445 Methods for eliciting or enhancing reactivity to HER-2/neu protein
02/09/1999US5869240 Computerized data analysis using polymer fragments produced by hydrolysis, measuring mass-to-charge ratio of pairs of fragments, statistically analyzing data, and repeating if necessary; sensitive and rapid analysis
02/09/1999CA1340381C Recombinant fusion proteins
02/04/1999WO1999005268A1 Production of erythropoietin by endogenous gene activation
02/04/1999WO1999005164A1 Process for preparing pharmacologically acceptable salts of n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanyl amino acids
02/04/1999WO1999005163A1 Refolding method using a foldase and a chaperone
02/04/1999WO1999004895A1 Compositions for the storage and delivery of solid phase reactive particles and methods of using the same
02/04/1999DE19832405A1 Isolation of N6-tri:fluoro-acetyl-lisinopril ethyl ester from aqueous solutions
02/04/1999CA2298015A1 Production of erythropoietin by endogenous gene activation
02/04/1999CA2292845A1 Refolding method using a foldase and a chaperone
02/03/1999EP0894094A1 Process for extraction of a growth factor complex
02/03/1999EP0894091A1 Method for purification of a protein from a protein containing solution
02/03/1999EP0894090A1 Extraction and purification of hyaluronidase from crustacean waste
02/03/1999EP0786085A4 Method and apparatus for efficient mimotope discovery
02/03/1999CN1207130A Carboxypeptidases from aspergillus oryzar and nucleic acids encoding same
02/03/1999CN1207046A Type IX collagen and chimeras
02/02/1999US5866690 Human anti-malignin antibody
02/02/1999US5866418 Filtration; ion exchanging; ulcers, gastrointestinal disorders
02/02/1999US5866362 Protein aggregates obtained by a process comprising culturing a host cell that expresses a desired protein in a medium comprising an effective amount of cu++ and wherein the desired protein forms inclusion bodies in the host cell.
02/02/1999US5866341 Compositions and methods for screening drug libraries
02/02/1999US5866334 Determination and identification of active compounds in a compound library
02/02/1999US5866122 Using prothrombinase
02/02/1999CA1340379C Antimicrobial peptide, compositions containing same and uses thereof
02/02/1999CA1340372C Production of e. coli lt-b enterotoxin subunit
02/02/1999CA1340363C Mutant acidic fibroblast growth factor
01/1999
01/28/1999WO1999003877A1 Methods of unfolding proteins using metal complexes
01/28/1999WO1999003488A2 Biologically active peptides with reduced toxicity in animals and a method for preparing same
01/28/1999WO1998046623A3 Purification of peptides and oligonucleotides by sample displacement chromatography process and apparatus
01/28/1999CA2297362A1 Methods of unfolding proteins using metal complexes
01/28/1999CA2294518A1 Biologically active peptides with reduced toxicity in animals and a method for preparing same
01/27/1999EP0893450A1 Chromatographic method for high yield purification and viral inactivation of antibodies
01/27/1999EP0893449A1 Antitumor substance extracted from hen-of-the-woods
01/27/1999EP0893439A1 Polypeptides modified by carbonates of polyalkylene oxide polymers
01/27/1999EP0892812A2 Agonist peptide dimers
01/27/1999EP0892810A1 Crystallization of a protein with a sulphur salt
01/27/1999EP0765125B1 Process for the fractionation of whey constituents
01/27/1999EP0602154B1 Selective affinity material, preparation thereof by molecular imprinting, and use of the same
01/27/1999EP0602032B1 Method of preferential labelling of a phycobiliprotein with a second dye to enable multiple color assay
01/27/1999EP0558671B1 Synthesis of equimolar multiple oligomer mixtures, especially of oligopeptide mixtures
01/27/1999EP0542770B1 Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
01/27/1999EP0461177B1 Human intra-acrosomal sperm antigen for use in a contraceptive vaccine
01/27/1999CN1206421A Apolipoprotein Ez and treatment of alzheimer's disease
01/27/1999CN1206348A Extracts of shark cartilage